Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shu Sen Wang

Showing results (41-50 of 60) with videos related to

Pageof 6
Sort By:
Chinese Journal of Cancer|August 9, 2014
Predictive factors for the local recurrence and distant metastasis of phyllodes tumors of the breast: a retrospective analysis of 192 cases at a single centerJing Wei, Yu-Ting Tan, Yu-Cen Cai, et al.
Medical Oncology (Northwood, London, England)|February 9, 2011
Comparison of overall survival between the early use and delayed use of Trastuzumab therapy groups: a retrospective analysis of 128 patients with HER-2-positive advanced breast cancerYan-Xia Shi, Yu-Ting Tan, Zhong-Yu Yuan, et al.
AI Zheng = Aizheng = Chinese Journal of Cancer|April 15, 2006
[Efficacy of rituximab-containing salvage regimens on relapsed or refractory B-cell non-Hodgkin's lymphoma]Hui-Qiang Huang, Qing Bu, Zhong-Jun Xia, et al.
AI Zheng = Aizheng = Chinese Journal of Cancer|April 12, 2005
[Clinical analysis of 59 cases of primary gastric non-Hodgkin's lymphoma]Yi-Fu He, Yu-Hong Li, Hui-Qiang Huang, et al.
Oncotarget|September 18, 2015
High PD-L1 expression was associated with poor prognosis in 870 Chinese patients with breast cancerTao Qin, Yin-duo Zeng, Ge Qin, et al.
Disease Markers|June 12, 2015
Elevated ZNF703 Protein Expression Is an Independent Unfavorable Prognostic Factor for Survival of the Patients with Head and Neck Squamous Cell CarcinomaHang Yang, Wen-Qi Jiang, Ye Cao, et al.
AI Zheng = Aizheng = Chinese Journal of Cancer|December 14, 2007
[Responses of 109 adult soft tissue sarcoma patients to chemotherapy]Miao-Zhen Qiu, Fei Xu, Shu-Sen Wang, et al.
Journal of Cancer Research and Clinical Oncology|January 13, 2012
Comparison of clinicopathological characteristics and prognoses between bilateral and unilateral breast cancerYan-Xia Shi, Qing Xia, Rou-Jun Peng, et al.
The Lancet. Oncology|November 27, 2025
Metronomic capecitabine as extended adjuvant chemotherapy for early triple-negative breast cancer (SYSUCC-001): updated 10-year outcomes and post-hoc exploratory biomarker analysis from a randomised, phase 3 trialJing Yuan, Xi-Wen Bi, Xin Hua, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 23, 2021
Trastuzumab Plus Endocrine Therapy or Chemotherapy as First-line Treatment for Patients with Hormone Receptor-Positive and HER2-Positive Metastatic Breast Cancer (SYSUCC-002)Xin Hua, Xi-Wen Bi, Jian-Li Zhao, et al.
Pageof 6

Showing results (41-50 of 60) with videos related to

Sort By:
Pageof 6
Chinese Journal of Cancer|August 9, 2014
Predictive factors for the local recurrence and distant metastasis of phyllodes tumors of the breast: a retrospective analysis of 192 cases at a single centerJing Wei, Yu-Ting Tan, Yu-Cen Cai, et al.
Medical Oncology (Northwood, London, England)|February 9, 2011
Comparison of overall survival between the early use and delayed use of Trastuzumab therapy groups: a retrospective analysis of 128 patients with HER-2-positive advanced breast cancerYan-Xia Shi, Yu-Ting Tan, Zhong-Yu Yuan, et al.
AI Zheng = Aizheng = Chinese Journal of Cancer|April 15, 2006
[Efficacy of rituximab-containing salvage regimens on relapsed or refractory B-cell non-Hodgkin's lymphoma]Hui-Qiang Huang, Qing Bu, Zhong-Jun Xia, et al.
AI Zheng = Aizheng = Chinese Journal of Cancer|April 12, 2005
[Clinical analysis of 59 cases of primary gastric non-Hodgkin's lymphoma]Yi-Fu He, Yu-Hong Li, Hui-Qiang Huang, et al.
Oncotarget|September 18, 2015
High PD-L1 expression was associated with poor prognosis in 870 Chinese patients with breast cancerTao Qin, Yin-duo Zeng, Ge Qin, et al.
Disease Markers|June 12, 2015
Elevated ZNF703 Protein Expression Is an Independent Unfavorable Prognostic Factor for Survival of the Patients with Head and Neck Squamous Cell CarcinomaHang Yang, Wen-Qi Jiang, Ye Cao, et al.
AI Zheng = Aizheng = Chinese Journal of Cancer|December 14, 2007
[Responses of 109 adult soft tissue sarcoma patients to chemotherapy]Miao-Zhen Qiu, Fei Xu, Shu-Sen Wang, et al.
Journal of Cancer Research and Clinical Oncology|January 13, 2012
Comparison of clinicopathological characteristics and prognoses between bilateral and unilateral breast cancerYan-Xia Shi, Qing Xia, Rou-Jun Peng, et al.
The Lancet. Oncology|November 27, 2025
Metronomic capecitabine as extended adjuvant chemotherapy for early triple-negative breast cancer (SYSUCC-001): updated 10-year outcomes and post-hoc exploratory biomarker analysis from a randomised, phase 3 trialJing Yuan, Xi-Wen Bi, Xin Hua, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 23, 2021
Trastuzumab Plus Endocrine Therapy or Chemotherapy as First-line Treatment for Patients with Hormone Receptor-Positive and HER2-Positive Metastatic Breast Cancer (SYSUCC-002)Xin Hua, Xi-Wen Bi, Jian-Li Zhao, et al.
Pageof 6